[HTML][HTML] The Effectiveness of Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitors on Cardiovascular Outcomes and All-Cause Mortality in Patients With Acute …
T Sinha, F Khilji, FNU Laraib, F Fatima, M Kaur… - Cureus, 2024 - ncbi.nlm.nih.gov
The aim of this systematic review and meta-analysis was to investigate the impact of early
sodium-glucose cotransporter-2 (SGLT2) initiation on long-term cardiovascular outcomes …
sodium-glucose cotransporter-2 (SGLT2) initiation on long-term cardiovascular outcomes …
Asian perspective on the recently published practice guideline for acute coronary syndrome by ESC
S Torii, CE Chiang, SJ Hong, S Goto… - … Heart Journal: Acute …, 2024 - academic.oup.com
The European Society of Cardiology (ESC) has recently issued an updated set of guidelines
pertaining to the management of acute coronary syndrome (ACS). 1 Typically, these …
pertaining to the management of acute coronary syndrome (ACS). 1 Typically, these …
Focus on prevention in diabetes mellitus and lipid disorder
S Agewall - European Heart Journal-Cardiovascular …, 2023 - academic.oup.com
Dr See and co-workers from Taiwan aimed to compare the specified outcomes in patients
with type 2 diabetes (T2D) after percutaneous coronary intervention (PCI) who were treated …
with type 2 diabetes (T2D) after percutaneous coronary intervention (PCI) who were treated …